Emerging as a significant development in the battle against obesity, the drug is attracting considerable attention . It combines properties of two recognized GLP-1 receptor agonists, dulaglutide , and an new glucose-dependent peptide component. Early study findings have indicated significant body decrease in individuals with excessive weight, poten